z-logo
open-access-imgOpen Access
Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites
Author(s) -
Tatsuo Kanda,
Reina Sasaki,
Ryota Masuzaki,
Mitsuhiko Moriyama
Publication year - 2021
Publication title -
artificial intelligence in gastroenterology
Language(s) - English
Resource type - Journals
ISSN - 2644-3236
DOI - 10.35712/aig.v2.i1.1
Subject(s) - virology , artificial intelligence , computer science , drug development , hepatitis virus , computational biology , drug , hepatitis , biology , pharmacology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here